MFSD2A and Huntington disease: By comparing snRNA-seq datasets of vascular cells between control and HD patients, a recent study showed that endothelial cells in HD display significant downregulation of MFSD2A [17], a lipid transporter that restricts caveola-mediated transcytosis (Figure 3) [29].